Siria Medici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Siria Medici has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Silvano Gnesin
Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
3 shared publications - Andreas Pitzschke
École Polytechnique Fédérale de Lausanne
2 shared publications - François Bochud
Institute of Radiation Physics Lausanne University Hospital Lausanne Vaud Switzerland
2 shared publications - Jerome Damet
Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland
2 shared publications - John Olivier Prior
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
2 shared publications - Niklaus Schaefer
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland
2 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Elsevier in Zeitschrift für Medizinische Physik
Swiss survey and national diagnostic reference levels for PET/CT examinations in adults
- 7 August 2026
- Published by Elsevier in Zeitschrift für Medizinische Physik
Open AccessSwiss survey and national diagnostic reference levels for PET/CT examinations in adults
- 25 November 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (2) , 107926
Superselective Intra-Arterial Lutetium-177 Prostate-Specific Membrane Antigen Therapy for Localized Nodal Metastasis in Prostate Cancer: A Case Report
- 25 November 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (2) , 107926
Superselective Intra-Arterial Lutetium-177 Prostate-Specific Membrane Antigen Therapy for Localized Nodal Metastasis in Prostate Cancer: A Case Report
- Open Access
- 25 April 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (12) , 4456-4466
Lung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening
Purpose: To assess feasibility of lung cancer screening, we analysed lung lesion detectability simulating low-dose and convolutional neural network (CNN) denoised [18F]-FDG PET/CT reconstructions. Methods: Retrospectively, we analysed lung lesions on full statistics and decimated [18F]-FDG PET/CT. Reduced count PET data were emulated according to various percentage levels of total. Full and reduced statistics datasets were denoised using a CNN algorithm trained to recreate full statistics PET. Two readers assessed a detectability score from 3 to 0 for each lesion. The resulting detectability score and quantitative measurements were compared between full statistics and the different decimation levels (100%, 30%, 5%, 2%, 1%) with and without denoising. Results: We analysed 141 lung lesions from 49 patients across 588 reconstructions. The dichotomised lung lesion malignancy score was significantly different from 10% decimation without denoising (p < 0.029) and from 5% decimation with denoising (p < 0.001). Compared to full statistics, detectability score distribution differed significantly from 2% decimation without denoising (p < 0.001) and from 5% decimation with denoising (p < 0.001). Detectability scores at same decimation levels with or without denoising differed significantly at 10%, 2%, and 1% decimation (p < 0.019); dichotomised scores did not differ significantly. Denoising significantly increased the proportion of lung lesion scores with a high diagnostic confidence (3 and 0) (p < 0.038). Conclusion: Lung lesion detectability was preserved down to 30% of injected activity without denoising and to 10% with denoising. These results support the feasibility of reduced-activity [18F]-FDG PET/CT as a potential tool for lung lesion detection. Further studies are warranted to compare this approach with low-dose CT in screening settings.
- 25 April 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (12) , 4456-4466
Open AccessLung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening
Purpose: To assess feasibility of lung cancer screening, we analysed lung lesion detectability simulating low-dose and convolutional neural network (CNN) denoised [18F]-FDG PET/CT reconstructions. Methods: Retrospectively, we analysed lung lesions on full statistics and decimated [18F]-FDG PET/CT. Reduced count PET data were emulated according to various percentage levels of total. Full and reduced statistics datasets were denoised using a CNN algorithm trained to recreate full statistics PET. Two readers assessed a detectability score from 3 to 0 for each lesion. The resulting detectability score and quantitative measurements were compared between full statistics and the different decimation levels (100%, 30%, 5%, 2%, 1%) with and without denoising. Results: We analysed 141 lung lesions from 49 patients across 588 reconstructions. The dichotomised lung lesion malignancy score was significantly different from 10% decimation without denoising (p < 0.029) and from 5% decimation with denoising (p < 0.001). Compared to full statistics, detectability score distribution differed significantly from 2% decimation without denoising (p < 0.001) and from 5% decimation with denoising (p < 0.001). Detectability scores at same decimation levels with or without denoising differed significantly at 10%, 2%, and 1% decimation (p < 0.019); dichotomised scores did not differ significantly. Denoising significantly increased the proportion of lung lesion scores with a high diagnostic confidence (3 and 0) (p < 0.038). Conclusion: Lung lesion detectability was preserved down to 30% of injected activity without denoising and to 10% with denoising. These results support the feasibility of reduced-activity [18F]-FDG PET/CT as a potential tool for lung lesion detection. Further studies are warranted to compare this approach with low-dose CT in screening settings.
- Open Access
- 1 August 2020
- Published by Elsevier in Radiation Measurements
- Vol. 136
Use of portable gamma spectrometers for triage monitoring following the intake of conventional and novel radionuclides
- 1 August 2020
- Published by Elsevier in Radiation Measurements
- Vol. 136
Open AccessUse of portable gamma spectrometers for triage monitoring following the intake of conventional and novel radionuclides
- 1 March 2019
- Published by Elsevier in Radiation Measurements
- Vol. 122, 126-132
Detecting intake of radionuclides: In vivo screening measurements with conventional radiation protection instruments
- 1 March 2019
- Published by Elsevier in Radiation Measurements
- Vol. 122, 126-132
Detecting intake of radionuclides: In vivo screening measurements with conventional radiation protection instruments
- 1 November 2017
- Published by Elsevier in Physica Medica
- Vol. 43, 140-147
Eye lens radiation exposure of the medical staff performing interventional urology procedures with an over-couch X-ray tube
- 1 November 2017
- Published by Elsevier in Physica Medica
- Vol. 43, 140-147
Eye lens radiation exposure of the medical staff performing interventional urology procedures with an over-couch X-ray tube